Barclays PLC Biotechnology

Barclays PLC

  • $854 Billion
  • Q3 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
NVO
Novo Nordisk A S
PUT
$133 Million
2.4M
Q3 2025
Added 36.91%
NVO
Novo Nordisk A S
CALL
$50.9 Million
917K
Q3 2025
Added 36.91%
RCUS
Arcus Biosciences, Inc.
CALL
$17.2 Million
1.27M
Q3 2025
Reduced 28.21%
QURE
Uni Qure N.V.
PUT
$11.1 Million
190K
Q3 2025
Added 29.82%
CORT
Corcept Therapeutics Inc
CALL
$10.4 Million
126K
Q3 2025
Reduced 78.13%
IONS
Ionis Pharmaceuticals Inc
CALL
$10.1 Million
155K
Q3 2025
Added 22.42%
IONS
Ionis Pharmaceuticals Inc
PUT
$9.61 Million
147K
Q3 2025
Added 22.42%
CRSP
Crispr Therapeutics Ag
PUT
$9.43 Million
146K
Q3 2025
Reduced 8.08%
JAZZ
Jazz Pharmaceuticals PLC
CALL
$8.63 Million
65.5K
Q3 2025
Added 26.09%
LQDA
Liquidia Corp
PUT
$8.29 Million
361K
Q3 2025
Reduced 31.01%
MRNA
Moderna, Inc.
PUT
$7.91 Million
306K
Q3 2025
Reduced 7.84%
CYTK
Cytokinetics Inc
CALL
$7.29 Million
133K
Q3 2025
Reduced 19.22%
RARE
Ultragenyx Pharmaceutical Inc.
CALL
$6.02 Million
200K
Q3 2025
Added 138.14%
QURE
Uni Qure N.V.
CALL
$5.44 Million
93.2K
Q3 2025
Added 29.82%
SRPT
Sarepta Therapeutics, Inc.
CALL
$5.34 Million
277K
Q3 2025
Reduced 27.32%
MRNA
Moderna, Inc.
CALL
$4.45 Million
172K
Q3 2025
Reduced 7.84%
BGNE
Bei Gene, Ltd.
CALL
$3.06 Million
13.5K
Q3 2025
Reduced 46.16%
BGNE
Bei Gene, Ltd.
PUT
$3.06 Million
13.5K
Q3 2025
Reduced 46.16%
INSM
Insmed Inc
PUT
$3.02 Million
21K
Q3 2025
Reduced 39.54%
INSM
Insmed Inc
CALL
$3.02 Million
21K
Q3 2025
Reduced 39.54%
INCY
Incyte Corp
CALL
$2.29 Million
27K
Q3 2025
Reduced 52.62%
INCY
Incyte Corp
PUT
$2.29 Million
27K
Q3 2025
Reduced 52.62%
VRTX
Vertex Pharmaceuticals Inc
PUT
$1.57 Million
4K
Q3 2025
Reduced 9.78%
ROIV
Roivant Sciences Ltd.
CALL
$1.47 Million
97.3K
Q3 2025
Reduced 42.84%
SRPT
Sarepta Therapeutics, Inc.
PUT
$1.35 Million
70K
Q3 2025
Reduced 27.32%
ARCT
Arcturus Therapeutics Holdings Inc.
CALL
$1.26 Million
68.5K
Q3 2025
Reduced 13.55%
BBIO
Bridge Bio Pharma, Inc.
PUT
$1.06 Million
20.4K
Q3 2025
Reduced 22.93%
FOLD
Amicus Therapeutics, Inc.
PUT
$898,000
114K
Q3 2025
Reduced 18.03%
DYN
Dyne Therapeutics, Inc.
PUT
$800,000
63.3K
Q3 2025
Added 49.99%
TARS
Tarsus Pharmaceuticals, Inc.
CALL
$754,000
12.7K
Q3 2025
Reduced 27.79%
NUVL
Nuvalent, Inc.
CALL
$743,000
8.6K
Q3 2025
Reduced 15.19%
CAPR
Capricor Therapeutics, Inc.
PUT
$610,000
84.1K
Q3 2025
Reduced 57.92%
SRRK
Scholar Rock Holding Corp
PUT
$313,000
8.4K
Q3 2025
Added 20.81%
ACLX
Arcellx, Inc.
CALL
$303,000
3.7K
Q3 2025
Reduced 22.76%
ACLX
Arcellx, Inc.
PUT
$303,000
3.7K
Q3 2025
Reduced 22.76%
RGNX
Regenxbio Inc.
PUT
$206,000
21.4K
Q3 2025
Reduced 5.68%
RGNX
Regenxbio Inc.
CALL
$206,000
21.4K
Q3 2025
Reduced 5.68%
REPL
Replimune Group, Inc.
CALL
$155,000
37K
Q3 2025
Added 22.51%
MLTX
Moon Lake Immunotherapeutics
CALL
$57,000
8K
Q3 2025
Reduced 99.65%
ROIV
Roivant Sciences Ltd.
PUT
$16,000
1.1K
Q3 2025
Reduced 42.84%
MREO
Mereo Biopharma Group PLC
CALL
$11,000
5.6K
Q4 2023
Reduced 50.0%
Filter Shares Options
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email